CompletedPhase 2NCT00029380
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Studying Sickle cell anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Victor AquinoUniversity of Texas Southwestern Medical Center - Dallas
- Intervention
- Sangstat(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 3-14 years · All sexes
- Timeline
- 1999 – 2006
Study locations (15)
- Children's Hospital Oakland, Oakland, California, United States
- Children's Hospital, Oakland, Oakland, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- University of Miami Batchelor Children's Research Center, Miami, Florida, United States
- Children's Memorial Hospital, Chicago, Illinois, United States
- Louisiana State University Children's Medical Center, New Orleans, Louisiana, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Duke University Medical Center Children's Hospital, Durham, North Carolina, United States
- Children's Hospital Philadelphia, Philadelphia, Pennsylvania, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
- Texas Transplant Institute, San Antonio, Texas, United States
- Hopital Ste-Justine, Montreal, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00029380 on ClinicalTrials.govOther trials for Sickle cell anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07369024Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young AdultsMohsen Saidinejad
- RECRUITINGNCT07373639A Long-term Follow-up Study in Patients Who Received BEAM-101Beam Therapeutics Inc.
- RECRUITINGNANCT07402811Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell DiseaseUniversity of Illinois at Chicago
- RECRUITINGPHASE1NCT06647979Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-HemoglobinopathiesDaniel Bauer
- RECRUITINGNANCT06555939Promoting Resilience Among Adolescents and Young Adults With Sickle Cell DiseaseBoston Children's Hospital
- RECRUITINGPHASE3NCT06975865The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseSanofi
- RECRUITINGNCT06944067Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell DiseaseNational Human Genome Research Institute (NHGRI)
- RECRUITINGNCT06923111PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]Nova Laboratories Limited